Talk:Pharmaceutical marketing

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia


Marketing budget "far exceeds" R&D[edit]

I hear this claim a lot, but the sources given don't link to a primary source of info. One commonly cited source on the web is this BBC article, but it no longer shows the table: https://www.bbc.com/news/business-28212223 ...but I found the data at archive.org: https://web.archive.org/web/20141119101441/https://www.bbc.com/news/business-28212223 As a source, it just says a GlobalData study, but no link.

This article relies on industry self-reporting (though the data was given to Congress, so probably isn't an outright lie): https://www.raps.org/news-and-articles/news-articles/2019/7/do-biopharma-companies-really-spend-more-on-market

I've removed these references:

Also, the Skeptical Inquirer link is only available to subscribers: https://skepticalinquirer.org/2018/03/drug-therapy-hype-the-misuse-of-data/

More review and sources would be good. (I forgot to sign my comment.) Unclevinny (talk) 19:37, 15 December 2022 (UTC)[reply]

4.2 plagiarism[edit]

While I do not have any better information, the first three paragraphs of section "Regulation and fraud", subsection "United States", are lifted almost verbatim from the New York Times. As a student attempting to find more information, it was frustrating to not only use another computer to circumvent the paywall, but to also find the exact same text I had just read. 163.11.62.69 (talk) 16:28, 12 December 2022 (UTC)[reply]

Wiki Education assignment: Research Process and Methodology - FA23 - Sect 202 - Thu[edit]

This article was the subject of a Wiki Education Foundation-supported course assignment, between 6 September 2023 and 14 December 2023. Further details are available on the course page. Student editor(s): ChrisMisu (article contribs).

— Assignment last updated by ChrisMisu (talk) 02:38, 17 November 2023 (UTC)[reply]

Substantial improvement needed[edit]

This page is IMHO currently missing the most fundamental criteria of quality and objectivity of information. The incipit used to be not a definition of the term, as it should be.

Furthermore, the information included in the page is currently US-centric, while any breadth of information about pharma marketing practices in other parts of the world are missing.

Finally, the choice of sources is IMHO weak and contentious.

I'm going to have this substantially improved. Ferdinando Scala (talk) 17:57, 12 December 2023 (UTC)[reply]